Showing 1841-1850 of 7004 results for "".
The FDA Drug-Approval Process for Allergy Products
https://reachmd.com/programs/hot-topics-in-allergy/the-fda-drug-approval-process-for-allergy-products/4459/What phases does the FDA use to approve a new medication, and why does this process take several years? Why must the active and excipient components of the medication, as well as the device, complete all of the testing phases? Dr. Warner Carr, allergist at Allergy and Asthma Associates in Mission ViRobotic Surgery for Prostate Cancer Patients
https://reachmd.com/programs/clinicians-roundtable/robotic-surgery-for-prostate-cancer-patients/3177/Are your patients potential candidates for robotic prostatectomy? How precisely does robotic surgery treat prostate cancer while maintaining urinary and sexual function? Host Dr. Bruce Bloom addresses these questions with Dr. Ash Tewari, associate professor of urology, and director of Robotic ProstaOvarian Function, Fertility, and Cancer Therapy
https://reachmd.com/programs/advances-in-womens-health/ovarian-function-fertility-and-cancer-therapy/1722/Dr. Gracia and Dr. Mazzullo discuss ovarian function and fertility before, during and after cancer treatments. The new ways in which we are beginning to perserve fertility provides hope for young cancer patients.Problems During Wilderness Treks and Travel
https://reachmd.com/programs/clinicians-roundtable/problems-during-wilderness-treks-and-travel/1055/What if you your are lost in the mountains and out of water? What if you need to take care of a snakebite victim on a mountain trail? Dr. Goodspeed gives all the answers as he continues the discussion of his recently published book, "What If? A Survival Guide For Physicians."Initiating Colorectal Cancer Screening Earlier: A Look at the Evidence
https://reachmd.com/programs/clinicians-roundtable/initiating-colorectal-cancer-screening-earlier-a-look-at-the-evidence/36540/In light of guidelines for the starting age of colorectal cancer screening shifting, a recent study explored how screening outcomes compare in adults age 45 to 49 and adults over 50. Across metrics like initiation, adherence, adenoma detection, and colonoscopy yield, the evidence shows support for eCases From The Real World: A Long Battle With BRVO-ME
https://reachmd.com/programs/cme/Cases-From-The-Real-World-A-Long-Battle-With-BRVO-ME/33170/Join Drs. Yasha Modi and Ferhina Ali as they dive into the challenges of treating RVO-ME and the effectiveness of traditional and emerging agents.Treatment of OAB and the Managed Care Professional: Balancing the Double-Edged Sword
https://reachmd.com/programs/cme/treatment-of-oab-and-the-managed-care-professional-balancing-the-double-edged-sword/15362/Are you prepared to actively engage with your patients about their overactive bladder?Using Biomarkers to Guide Severe Asthma Treatment
https://reachmd.com/programs/clinicians-roundtable/using-biomarkers-to-guide-severe-asthma-treatment/54214/Biomarkers and biologic phenotyping are essential for guiding treatment selection in severe asthma, helping clinicians match therapies to underlying disease pathways. In this episode, Dr. Geoffrey Chupp—Director of the Yale Center for Asthma and Airways Disease and Professor at Yale School of MediciIBD and Biosimilars: What Healthcare Professionals Need to Know
https://reachmd.com/programs/gi-insights/ibd-and-biosimilars-what-healthcare-professionals-need-to-know/13835/Do you know how the approval of biosimilars will impact the treatment of inflammatory bowel disease? Hear from our experts and stay up to date!TROP2 ADCs for Metastatic NSCLC: Setting the Stage for Future Use
https://reachmd.com/programs/cme/trop2-adcs-for-metastatic-nsclc-setting-the-stage-for-future-use/14416/Are you as excited as we are to see how TROP2-targeted antibody-drug conjugates can help our patients?